Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Dermatology

Protecting Your Skin: Wound Care and Surgical Risks

At a Glance

In PASH syndrome, skin trauma can trigger pathergy and turn a minor wound or procedure site into a worsening pyoderma gangrenosum ulcer. Protect wounds with non-adherent dressings and specialist-guided care, and control inflammation before elective procedures.

Managing the skin in PASH syndrome requires a delicate balance. Because your immune system is in a state of high alert, your skin can react to trauma by producing new inflammation rather than healing [1][2]. This response is known as pathergy, and it is the reason why standard surgical and wound care techniques must be carefully modified for you [3].

The Danger of Pathergy in Surgery

In a typical patient, a doctor might “lance” (perform an incision and drainage or I&D) a painful abscess to relieve pressure and infection. However, in PASH, this can be a major hazard [1].

  • The Reaction: For someone with PASH, the trauma of the incision can signal the immune system to attack the site. What started as a simple abscess can sometimes quickly transform into an expanding pyoderma gangrenosum (PG) ulcer [1][4].
  • Surgical Risk: This risk extends to all types of surgery, including biopsies and elective procedures for hidradenitis suppurativa (HS) [1]. In one small series of patients with both HS and PG, a high percentage developed a new PG ulcer at the surgical site following standard I&D [1].

Because of this, elective surgery is generally avoided while your disease is active. If a procedure is absolutely necessary, it should ideally be performed only after your inflammation is well-controlled by medications [5][6]. However, pathergy risk should never cause you to delay urgent life-saving drainage of a suspected deep or necrotizing infection.

Debridement: A Specialist’s Decision

Debridement is the process of removing dead or infected tissue from a wound to help it heal. Debridement decisions must be made by a specialist team, as even gentle manipulation can sometimes trigger pathergy. You should never attempt to self-debride or “pop” wounds at home [3][7]. What appears to be “dead” tissue may actually be active inflammation or infection requiring specialist care.

Daily Wound Management Principles

Your daily goal is to protect your skin from trauma while managing the fluid (exudate) and pain associated with your ulcers [8][9].

  1. Atraumatic Care: Always use non-adherent dressings (dressings that won’t stick to the wound bed) as directed by your clinician. When a dressing sticks, removing it can cause minor trauma that triggers pathergy [10].
  2. Avoid Adhesives: Whenever possible, avoid applying strong adhesive tapes directly to the skin near a wound. Use soft silicone adhesives or wrap-around bandages (like Gauze) to hold dressings in place [10].
  3. Moisture Balance: PG and HS wounds can produce significant amounts of fluid. Your wound care team may use absorbent foams or specialized moisture-balancing products to keep the wound moist enough to heal but dry enough to prevent the surrounding skin from becoming “soggy” or macerated [11].
  4. Gentle Cleansing: Avoid scrubbing the wound. Use gentle irrigation with sterile saline or a mild, non-irritating cleanser recommended by your dermatologist [8].

Specialized Tools: NPWT and Grafting

Once the underlying inflammation is calmed by systemic drugs, your care team may use advanced tools to speed up healing:

  • Negative-Pressure Wound Therapy (NPWT): Sometimes called a “wound vac,” this uses a vacuum dressing to pull out excess fluid. In PASH, this is almost always used alongside immunosuppressants to prevent it from causing trauma [12][6].
  • Skin Grafting: If a large ulcer is stable and no longer “active,” a skin graft can help close the wound. However, this is usually a last resort and is only done when the risk of the “donor site” turning into a new ulcer is low [6][13].

Managing Pain

The pain from PASH ulcers is often described as “out of proportion” to what can be seen [14]. Effective wound care must include a pain management plan, especially during dressing changes [14][15]. This may include topical numbing agents, systemic pain medications, or “pre-medicating” before your daily routine. (If your pain suddenly changes and worsens out of proportion, seek prompt review for infection). Restoring the integrity of the skin through biologics is ultimately the most effective way to resolve this chronic pain [14].

Common questions in this guide

Why can surgery or a biopsy be risky with PASH syndrome?
PASH syndrome can cause pathergy, meaning skin trauma triggers an exaggerated inflammatory response. An incision, biopsy, or drainage procedure may cause a new or expanding pyoderma gangrenosum ulcer at the site. Elective procedures are usually planned after inflammation is controlled, while suspected deep or life-threatening infection needs urgent medical care.
What should I do if I develop a painful abscess?
Do not pop, lance, or drain it yourself. Contact your dermatologist or urgent-care team promptly so they can assess for infection and choose the safest approach; pathergy risk should not delay emergency evaluation for a suspected deep or necrotizing infection.
What dressings are safest for PASH ulcers?
Clinicians often recommend non-adherent dressings that do not stick to the wound bed, with soft silicone or wrap-around methods instead of strong adhesive tape. Absorbent products may help manage drainage while preserving a balanced moisture level. Clean gently with sterile saline or a clinician-recommended mild cleanser, not by scrubbing.
Should wounds in PASH be debrided?
Debridement should be decided and performed by a specialist team because even gentle manipulation can trigger pathergy. Do not cut away tissue or try to pop a wound at home; tissue that looks dead may instead be active inflammation or infection.
Can I have surgery or a skin graft if I have PASH?
Elective surgery is often postponed until PASH inflammation is controlled and should be coordinated among dermatology, surgery, and wound-care specialists. A skin graft may be considered only for a stable, inactive ulcer when the donor site is unlikely to develop a new ulcer. The timing and medication plan must be individualized.
How can I control pain during PASH dressing changes?
Ask your care team for a plan that may include a topical numbing medicine, systemic pain medicine, or medication taken before dressing changes. Sudden worsening pain or pain that seems out of proportion should be reviewed promptly because it can signal infection. Treating the underlying inflammation is important for long-term pain relief.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my risk of pathergy, how do you plan to handle any necessary skin procedures like biopsies or debridement?
  2. 2.If I develop a new painful abscess, can we use an alternative to traditional incision and drainage (I&D) to avoid triggering a PG ulcer?
  3. 3.Are we coordinating with a specialized wound care team that understands autoinflammatory conditions like PASH?
  4. 4.What is our plan for perioperative immunosuppression if I ever require surgery for my hidradenitis sinus tracts?
  5. 5.Which specific non-adherent dressings or moisture-management tools do you recommend for my current ulcers?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Concurrent Hidradenitis Suppurativa and Pyoderma Gangrenosum in a Pediatric Cohort: A Retrospective Case Series.

    Wu V, Lara-Corrales I, Sibbald C, Levy R

    Journal of cutaneous medicine and surgery 2026; (30(2)):139-142 doi:10.1177/12034754251386763.

    PMID: 41189322
  2. 2

    Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis).

    Marzano AV, Damiani G, Ceccherini I, et al.

    The British journal of dermatology 2017; (176(6)):1588-1598 doi:10.1111/bjd.15226.

    PMID: 27943240
  3. 3

    Wound Debridement in Pyoderma Gangrenosum.

    Taheri A, Mansoori P, Sharif M

    Advances in skin & wound care 2024; (37(2)):107-111 doi:10.1097/ASW.0000000000000092.

    PMID: 38241454
  4. 4

    A Case of Overlapping Clinical Features of Idiopathic Granulomatous Mastitis, Hidradenitis Suppurativa, and Pyoderma Gangrenosum Successfully Treated with Adalimumab.

    Breznik V, Marko PB

    Case reports in dermatology 2022; (14(2)):98-106 doi:10.1159/000523801.

    PMID: 35702373
  5. 5

    Pyoderma gangrenosum after orthopaedic or traumatologic surgery: a systematic revue of the literature.

    Ebrad S, Severyns M, Benzakour A, et al.

    International orthopaedics 2018; (42(2)):239-245 doi:10.1007/s00264-017-3672-2.

    PMID: 29119297
  6. 6

    Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

    Eisendle K, Thuile T, Deluca J, Pichler M

    Advances in wound care 2020; (9(7)):405-425 doi:10.1089/wound.2020.1160.

    PMID: 32320362
  7. 7

    An aggressive course of pyoderma gangrenosum mimicking bacterial osteomyelitis after open reduction and internal fixation of a distal radius fracture with a titanium plate.

    Wasiak M, Ciszek M, Babiak I, et al.

    Reumatologia 2022; (60(4)):292-302 doi:10.5114/reum.2022.119046.

    PMID: 36186837
  8. 8

    PG-TIME: A practical approach to the clinical management of pyoderma gangrenosum.

    Janowska A, Oranges T, Fissi A, et al.

    Dermatologic therapy 2020; (33(3)):e13412 doi:10.1111/dth.13412.

    PMID: 32291879
  9. 9

    Pyoderma gangrenosum study pilot registry: The first step to a better understanding.

    Orfaly VE, Reese AM, Friedman M, et al.

    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2022; (30(3)):334-337 doi:10.1111/wrr.13005.

    PMID: 35363927
  10. 10

    Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review.

    Afifi L, Sanchez IM, Wallace MM, et al.

    Journal of the American Academy of Dermatology 2018; (78(6)):1195-1204.e1 doi:10.1016/j.jaad.2017.12.049.

    PMID: 29288099
  11. 11

    Improvement of Ulcerations in Treatment-Resistant Chronic Scarring in a Patient with Pyoderma Gangrenosum After Improving Vascular Insufficiency, Gently Removing Necrotic Debris, and Decreasing Wound Fluid.

    Nahm WJ, Mota JA, Rojas S, et al.

    The American journal of case reports 2018; (19()):844-848 doi:10.12659/AJCR.908995.

    PMID: 30022021
  12. 12

    The role of negative pressure wound therapy (NPWT) on the treatment of pyoderma gangrenosum: A systematic review and personal experience.

    Almeida IR, Coltro PS, Gonçalves HOC, et al.

    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2021; (29(3)):486-494 doi:10.1111/wrr.12910.

    PMID: 33772964
  13. 13

    Pyoderma gangrenosum following pelvic and femoral osteotomy in an 8-Year-Old Girl with Cri-du-chat syndrome: A case report.

    Eugster T, Lengnick H, Lotter L, et al.

    JPRAS open 2026; (52()):192-195 doi:10.1016/j.jpra.2026.08.026.

    PMID: 42730249
  14. 14

    Updates in innovation of the treatment of pyoderma gangrenosum.

    Keum H, Zhivov EV, Ortega-Loayza AG

    Expert review of clinical pharmacology 2025; (18(1-2)):29-39 doi:10.1080/17512433.2024.2447776.

    PMID: 39720859
  15. 15

    Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.

    Groleau PF, Grossberg AL, Gaspari AA

    Cutis 2015; (95(6)):337-42.

    PMID: 26125210

This page provides general information about wound care and procedure risks in PASH syndrome; it is not medical advice. Your dermatologist and wound-care or surgical team should guide dressing changes, debridement, and decisions about procedures.

Get notified when new evidence is published on PASH syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.